Latest Conference Articles

Dr. Chopra said an FDA-approved treatment for NAFLD could come in the next 6 months.

Dr. Gerald Smetana encourages PCPs to familiarize themselves with the outpatient drug options for managing COVID-19 because of the limited treatment window for administration.

Dr. Tara Vijayan talks about how primary care physicians can be best combat misinformation.

Expert psychiatrist Dr. Timothy Fong explains the complexity of using marijuana as treatment in a primary care setting and shares advice on how to address it with patients.

Alcohol use increased during the COVID-19 pandemic, leading to an increase in alcoholic hepatitis.

High-risk individuals should be targeted when drug scarcity comes into play.

NAFLD is currently the most prevalent liver disease in the US.

There remains a need to develop more antivirals that can be easily scaled up for COVID-19.

At Pri-Med West, primary care providers ask Dr. Michael Ziffra and Dr. Shirah Vollmer all the questions they have about treating mental illness and prescribing different classes of drugs.

Dr. Charles Vega suggestion doctors be less prescriptive in suggestion diets to patients.

Drugs like semaglutide are able to treat both diabetes and obesity.

Dr. Michael Ziffra talked during Pri-Med West 2022 about some of the challenges and gaps in research needed for better bipolar disorder care.

Expert nephrologist Dr. Rajeev Raghavan elaborates on the American Diabetes Association guideline updates for patients with diabetic kidney disease during Pri-Med West.

Dr. Rajeev Raghavan talks about the role of SGLT2 inhibitors and GLP-1 receptor agonists as new therapeutics available to slow progression of chronic kidney disease.

Jennifer Green discussed weight management and obesity during the annual Pri-Med West conference.

Pri-Med West presenter Dr. Rajeev Raghavan highlights the key points of his nephrology talk and identifies trending topics in the field during an interview.

The pandemic has removed some of the barriers of medicine.

Phone communication may have decreased in recent years among doctors.

In the first episode of this new game show, a team of ARVO 2022 investigators work to invent an innovative clinical trial.

Many people struggled with anxiety during the COVID-19 pandemic.

From curative stem cell approaches to in-clinic subretinal injections, Arshad Khanani, MD, MA, navigates what the future drug class may entail.

There remains a need for more doctors that specialize in geriatrics.

An FDA decision could come as soon as this year. One expert stresses the need for improved screening, biomarker research, and patient communication beforehand.

Many patients, particularly older ones, are taking unnecessary medications.

Early-stage prevention of modifiable risk factors may contribute to the prevention of neurodegenerative changes and diabetic retinopathy.

Study author Arshad Khanani, MD, MA, discusses how the novel-targeting gene therapy candidate may uniquely benefit patients with treated retina disease.

Theodore Leng, MD, MS, discusses his team's IRIS registry findings suggesting a need for quantifying how vision-loss patients are impacted by functional or quality-of-life measures.

Data show half of all eyes with CRVO were still being treated at 36-months.